THE EXPRESSION OF MISMATCH REPAIR GENES (MLH1 AND MSH2) AND TUMOR SUPPRESSOR GENE (BRCA1 AND P53) IN HUMAN MELANOMA CELL LINES AFTER UVB-IRRADIATION
AbstractThe aim of our study to investigate the susceptibility of melanoma to UVB-irradiation: by examine the expression of hMLh1,hMSH2,BRCA1 and P53 proteins. In our work, we cultured three human melanoma cell lines (Colo38,SK-MEL28 and SK-MEL93, ) in college of medicine university of magna-Gracia-Italy. We first, examined the expression of BRCA1, hMSH2, hMLH1 and p53 proteins by Western Blot analysis in Colo38, SK-MEL93 and SK-MEL28 cell lines. After that the cells were exposed to UV-B (10mJ/cm2)for different point time(1/2,1,3,6,9,12,and 24h). Cells at 0hr were a non-irradiation control. After exposure the expression of MLH1,MSH2,BRCA1 and p53 proteins were assessed by western Blot analysis. We found that the expression of BRCA1,hMSH2 and P53 proteins were increased at 3h after UV-B-irradiation in SK-MEL93 cells line, while, the same amount of the expression proteins in the Colo38 and SK-MEL28 cell lines were obtained . Moreover; our data detected an equal amounts of hMLH1protein in three cell lines, were involved in this study..
Iyer RR, Pluciennik A, Burdett V,& Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev. 2006;106(2):302-23.
Felipe Cavalcanti Carneiro da Silva, Mev Dominguez Valentin, Fabio de Oliveira Ferreira, Dirce Maria Carraro,& Benedito Mauro Rossi:Mismatch repair genes in Lynch syndrome.Sao Paulo Med J. 2009; 127(1):46-51.
de la Chapelle A.:The incidence of Lynch syndrome.Fam Cancer. 2005;4(3):233-7.
Papp J, Kovacs ME,& Olah E: Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary nonpolyposis colorectal cancer families: implications for genetic testing. World J Gastroenterol. 2007;13(19):2727-32.
Kolodner,R.D. & G.T.Marsischky. Eukaryotic DNA mismatch repair. Curr.Opin. Genet.Dev.1999;9:89-96.
Charles J Sheer: Principles of Tumor Supression.Cell. 2004; 116: 235-246.
Oliveira AM, Ross JS, Fletcher JA.: Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol .2005;124:S16-28.
Melino,G.,DeLaurenzi,V.&Vousden,K.H.:p73 and cancer: p73: Friend or foe in tumorigenesis. Nature Rev. Cancer.2002 ;2(8):605-15.
Irwin,M.S.&Kaelin,W.G:p53 family update:p73and p63develop their own identities. Cell Growth Differ.2001;12:337-349.
Balint,E & Vousden, K.H. Activation and activities of the p53 tumor suppressor protein .Br.J.Cancer 2002;85,1813-1823.
King, M.C., Marks, J.H. and Mandell, J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science.2003;302: 643–646.
Barbara Quaresima, Maria Concetta Faniello. Francesco Baudi, Telma Crugliano, Giovanni Cuda, Francesco Costanzo, & Salvatore Venuta: InVitro Analysis of Genomic Instability Triggered by BRCA1 Gene Missense Mutations.Hum Mutat. 2006;27(7)715.
Crugliano T, Quaresima B, Gaspari M, Faniello MC, Romeo F, Baudi F,CudaG. Costazo F & Venuta S. Specific change in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.Int JBiochem Cell Biol. 2007;39(1):220-226.
Rass K, &Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:162-178
Halmbach H, Rossman E, Korn M, Schadendorf D. Drug resistance in Human melanoma. Int J Cancer 2001;93:617-22
Joiner MC, Van Der Kogel AJ. The linear quadratic approach to fractionation and calculation of isoeffect relationships . In Stal GG, Editor. Basic Clinical Radiobiology. London; 1997. p107-21
Seifert M, Scherer SJ, Edelmann W, Bohm M, Meineke V, Lobrich M, Tilgen W&Reichrath J. The DNA-mismatch repair enzyme hMSH2 modulates UV-Binduced cell cycle arrest and apoptosis in melanoma cells. J Invest Dermatol.2008 ;128(1):203-213.
Stefan J et al. p53 and c-Jun functionally synergize in the regulation of theDNA repair gene hMSH2 in response to UV. J Biol Chem. 2000;275(48):37469-73.